Delivery Order SPE2DB25D7068-SPE2DB25FTXFF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,346.17 to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of Prilosec DR 10 mg suspension (30 count). This competitively awarded, firm fixed price delivery order is set to be completed by June 9, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs within DLA's...
- The Defense Logistics Agency awarded a $17,682.17 delivery order to AmerisourceBergen Drug Corp for Prilosec DR 2.5 MG Suspension (30-count), a proton pump inhibitor commonly used to treat gastroesophageal reflux disease and related gastrointestinal conditions. The contract, executed on July 21, 2025, with a completion date of July 22, 2025, employs firm fixed pricing and was competitively awarded with no set-aside designation. Performance of this delivery order occurs at the awardee's...
- The Defense Logistics Agency awarded a delivery order valued at $2,087.69 to AmerisourceBergen Drug Corp for PRILOSEC DR 10 MG Suspension (30-count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Prilosec DR 10 mg Suspension, a prescription medication, with a ceiling value of $10,532.34 and a performance period through July 10, 2023. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.17 firm fixed-price contract is for the supply of Prilosec DR 10 mg suspension medication, with a completion date of December 24, 2024. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Omeprazole DR 20 mg capsules in quantities of 1,000 units. This non-competitive, firm fixed-price delivery order has a ceiling value of $1,472.29 and is scheduled for completion by September 5, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a $1,533.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of 500 capsules of Omeprazole DR 40 mg. This is a non-set-aside contract with an ultimate completion date of July 28, 2025, and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 count) at a firm fixed price of $1,468.32, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3101|SPE2DB24FRBE2) from the Defense Logistics Agency (DLA) for the supply of Prilosec DR 2.5 mg Suspension, valued at $12,325.17. The contract has a ceiling value of $12,325.17 and an ultimate completion date of February 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 count) with a contract ceiling value of $1,792.19. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made without set-aside restrictions, indicating competitive procurement. This delivery...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTXFFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Prilosec DR 2.5 mg suspension (30-count units) with a ceiling value of $1,155.57. This competitively awarded, firm fixed-price delivery order is classified as a child contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 11, 2025. No set-aside designation was utilized for this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying pharmaceuticals and medical supplies to military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to deliver a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/10/25 |